EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular targeted therapies for cutaneous squamous cell carcinoma

Harpreet Singh, Hitesh Chopra, Inderbir Singh, Sourav Mohanto, Mohammed Gulzar Ahmed, Shruti Ghumra, Anmol Seelan, Manisha Survase, Arvind Kumar, Amrita Mishra, Arun Kumar Mishra, Mohammad Amjad Kamal

EXCLI Journal · 27.02.2024 · 23 · 300-334

DOI: 10.17179/excli2023-6489 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 27.02.2024. Verfasst von Harpreet Singh und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, IFTM University, Moradabad, U.P., India, 244102. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous Squamous Cell Carcinoma (cSCC) is a common and potentially fatal type of skin cancer that poses a significant threat to public health and has a high prevalence rate. Exposure to ultraviolet radiation on the skin surface increases the risk of cSCC, especially in those with genetic syndromes like xerodermapigmentosum and epidermolysis bullosa. Therefore, understanding the molecular pathogenesis of cSCC is critical for developing personalized treatment approaches that are effective in cSCC. This article provides a comprehensive overview of current knowledge of cSCC pathogenesis, emphasizing dysregulated signaling pathways and the significance of molecular profiling. Several limitations and challenges associated with conventional therapies, however, are identified, stressing the need for novel therapeutic strategies. The article further discusses molecular targets and therapeutic approaches, i.e., epidermal growth factor receptor inhibitors, hedgehog pathway inhibitors, and PI3K/AKT/mTOR pathway inhibitors, as well as emerging molecular targets and therapeutic agents. The manuscript explores resistance mechanisms to molecularly targeted therapies and proposes methods to overcome them, including combination strategies, rational design, and optimization. The clinical implications and patient outcomes of molecular-targeted treatments are assessed, including response rates and survival outcomes. The management of adverse events and toxicities in molecular-targeted therapies is crucial and requires careful monitoring and control. The paper further discusses future directions for therapeutic advancement and research in this area, as well as the difficulties and constraints associated with conventional therapies.

Schlagwörter

Stichwörter der Autor:innen

clinical implicationsclinical trialscombination strategiespatientskin cancer

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, IFTM University, Moradabad, U.P., India, 244102.
  • Department of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai - 602105, Tamil Nadu, India.
  • Chitkara College of Pharmacy, Chitkara University, Punjab, India.
  • Department of Pharmaceutics, Yenepoya Pharmacy College & Research Center, Yenepoya (Deemed to be University), Mangalore, Karnataka, 575018, India.
  • Department of Biological Sciences, Sunandan Divatia School of Science, NarseeMonjee Institute of Management Studies (NMIMS), Pherozeshah Mehta Rd, Mumbai, India, 400056.
  • Mahatma Gandhi Mission, Institute of Biosciences and Technology, Aurangabad, India.

Zitieren

APA

Singh, H., Chopra, H., Singh, I., Mohanto, S., Ahmed, M. G., Ghumra, S., Seelan, A., Survase, M., Kumar, A., Mishra, A., Mishra, A. K., & Kamal, M. A. (2024). Molecular targeted therapies for cutaneous squamous cell carcinoma. EXCLI Journal, 23, 300-334. https://doi.org/10.17179/excli2023-6489

Vancouver

Singh H, Chopra H, Singh I, Mohanto S, Ahmed MG, Ghumra S, et al. Molecular targeted therapies for cutaneous squamous cell carcinoma. EXCLI Journal. 2024;23:300-334. doi:10.17179/excli2023-6489

BibTeX
@article{Singh2024,
  author = {Singh, Harpreet and Chopra, Hitesh and Singh, Inderbir and Mohanto, Sourav and Ahmed, Mohammed Gulzar and Ghumra, Shruti and Seelan, Anmol and Survase, Manisha and Kumar, Arvind and Mishra, Amrita and Mishra, Arun Kumar and Kamal, Mohammad Amjad},
  title = {Molecular targeted therapies for cutaneous squamous cell carcinoma},
  journal = {EXCLI Journal},
  year = {2024},
  volume = {23},
  pages = {300--334},
  doi = {10.17179/excli2023-6489}
}
Kostenlos starten →